Cite
HARVARD Citation
Chan, A. et al. (n.d.). Neratinib after trastuzumab in patients with HER2-positive breast cancer – Author's reply. Lancet oncology. 17 (5), pp. e176-e177. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chan, A. et al. (n.d.). Neratinib after trastuzumab in patients with HER2-positive breast cancer – Author's reply. Lancet oncology. 17 (5), pp. e176-e177. [Online].